153 related articles for article (PubMed ID: 18008366)
1. Statin use and risk of breast cancer.
Pocobelli G; Newcomb PA; Trentham-Dietz A; Titus-Ernstoff L; Hampton JM; Egan KM
Cancer; 2008 Jan; 112(1):27-33. PubMed ID: 18008366
[TBL] [Abstract][Full Text] [Related]
2. The association between 3-hydroxy-3-methylglutaryl conenzyme A inhibitor use and breast carcinoma risk among postmenopausal women: a case-control study.
Boudreau DM; Gardner JS; Malone KE; Heckbert SR; Blough DK; Daling JR
Cancer; 2004 Jun; 100(11):2308-16. PubMed ID: 15160333
[TBL] [Abstract][Full Text] [Related]
3. Statin prescriptions and breast cancer recurrence risk: a Danish nationwide prospective cohort study.
Ahern TP; Pedersen L; Tarp M; Cronin-Fenton DP; Garne JP; Silliman RA; Sørensen HT; Lash TL
J Natl Cancer Inst; 2011 Oct; 103(19):1461-8. PubMed ID: 21813413
[TBL] [Abstract][Full Text] [Related]
4. Lipophilic statin use and risk of breast cancer subtypes.
Woditschka S; Habel LA; Udaltsova N; Friedman GD; Sieh W
Cancer Epidemiol Biomarkers Prev; 2010 Oct; 19(10):2479-87. PubMed ID: 20729289
[TBL] [Abstract][Full Text] [Related]
5. Estrogen receptor-negative breast cancer is less likely to arise among lipophilic statin users.
Kumar AS; Benz CC; Shim V; Minami CA; Moore DH; Esserman LJ
Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1028-33. PubMed ID: 18463402
[TBL] [Abstract][Full Text] [Related]
6. Statin use and breast cancer: prospective results from the Women's Health Initiative.
Cauley JA; McTiernan A; Rodabough RJ; LaCroix A; Bauer DC; Margolis KL; Paskett ED; Vitolins MZ; Furberg CD; Chlebowski RT;
J Natl Cancer Inst; 2006 May; 98(10):700-7. PubMed ID: 16705124
[TBL] [Abstract][Full Text] [Related]
7. Comparative risk of lipophilic and hydrophilic statins on incident depression: A retrospective cohort study.
Dave CV; Winterstein AG; Park H; Cook RL; Hartzema AG
J Affect Disord; 2018 Oct; 238():542-546. PubMed ID: 29936394
[TBL] [Abstract][Full Text] [Related]
8. Recent oral contraceptive use and risk of breast cancer (United States).
Newcomb PA; Longnecker MP; Storer BE; Mittendorf R; Baron J; Clapp RW; Trentham-Dietz A; Willett WC
Cancer Causes Control; 1996 Sep; 7(5):525-32. PubMed ID: 8877050
[TBL] [Abstract][Full Text] [Related]
9. Lipophilic Statins and the Risk of Intracranial Hemorrhage Following Ischemic Stroke: A Population-Based Study.
Quinn KL; Macdonald EM; Mamdani MM; Diong C; Juurlink DN;
Drug Saf; 2017 Oct; 40(10):887-893. PubMed ID: 28620871
[TBL] [Abstract][Full Text] [Related]
10. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
[TBL] [Abstract][Full Text] [Related]
11. Cigarette smoking and breast cancer.
Baron JA; Newcomb PA; Longnecker MP; Mittendorf R; Storer BE; Clapp RW; Bogdan G; Yuen J
Cancer Epidemiol Biomarkers Prev; 1996 May; 5(5):399-403. PubMed ID: 9162307
[TBL] [Abstract][Full Text] [Related]
12. Statins and risk of polyneuropathy: a case-control study.
Gaist D; Jeppesen U; Andersen M; García Rodríguez LA; Hallas J; Sindrup SH
Neurology; 2002 May; 58(9):1333-7. PubMed ID: 12011277
[TBL] [Abstract][Full Text] [Related]
13. Non-steroidal anti-inflammatory drugs and statins in relation to colorectal cancer risk.
Shadman M; Newcomb PA; Hampton JM; Wernli KJ; Trentham-Dietz A
World J Gastroenterol; 2009 May; 15(19):2336-9. PubMed ID: 19452574
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic comparison of the potential over-the-counter statins simvastatin, lovastatin, fluvastatin and pravastatin.
Neuvonen PJ; Backman JT; Niemi M
Clin Pharmacokinet; 2008; 47(7):463-74. PubMed ID: 18563955
[TBL] [Abstract][Full Text] [Related]
15. Statins, aspirin and risk of venous thromboembolic events in breast cancer patients.
Shai A; Rennert HS; Lavie O; Ballan-Haj M; Bitterman A; Steiner M; Keren S; Rennert G
J Thromb Thrombolysis; 2014 Jul; 38(1):32-8. PubMed ID: 24154915
[TBL] [Abstract][Full Text] [Related]
16. Variation in female breast cancer risk by occupation.
Coogan PF; Clapp RW; Newcomb PA; Mittendorf R; Bogdan G; Baron JA; Longnecker MP
Am J Ind Med; 1996 Oct; 30(4):430-7. PubMed ID: 8892548
[TBL] [Abstract][Full Text] [Related]
17. The relationship between statins and breast cancer prognosis varies by statin type and exposure time: a meta-analysis.
Liu B; Yi Z; Guan X; Zeng YX; Ma F
Breast Cancer Res Treat; 2017 Jul; 164(1):1-11. PubMed ID: 28432513
[TBL] [Abstract][Full Text] [Related]
18. Differential efficacy of 3-hydroxy-3-methylglutaryl CoA reductase inhibitors on the cell cycle of prostate cancer cells.
Sivaprasad U; Abbas T; Dutta A
Mol Cancer Ther; 2006 Sep; 5(9):2310-6. PubMed ID: 16985065
[TBL] [Abstract][Full Text] [Related]
19. Statin Use and Chronic Lymphocytic Leukemia Incidence: A Nested Case-Control Study in Manitoba, Canada.
Righolt CH; Zhang G; Ye X; Banerji V; Johnston JB; Gibson S; Mahmud SM
Cancer Epidemiol Biomarkers Prev; 2019 Sep; 28(9):1495-1501. PubMed ID: 31186266
[TBL] [Abstract][Full Text] [Related]
20. Lactation and a reduced risk of premenopausal breast cancer.
Newcomb PA; Storer BE; Longnecker MP; Mittendorf R; Greenberg ER; Clapp RW; Burke KP; Willett WC; MacMahon B
N Engl J Med; 1994 Jan; 330(2):81-7. PubMed ID: 8259187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
